CYTC

CYTC

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CYTC</th>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">Caspase Inhibitors</td>
<td>Block downstream execution</td>
</tr>
<tr>
<td class="label">BCL-2 Agonists</td>
<td>Prevent MOMP</td>
</tr>
<tr>
<td class="label">MitoQ</td>
<td>Mitochondrial antioxidant</td>
</tr>
<tr>
<td class="label">Cytochrome c Sequestration</td>
<td>Prevent cytosolic release</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Target</td>
</tr>
<tr>
<td class="label">VX-166</td>
<td>Caspase-9</td>
</tr>
<tr>
<td class="label">IDN-6556</td>
<td>Pan-caspase</td>
</tr>
<tr>
<td class="label">ABT-737</td>
<td>BCL-2</td>
</tr>
<tr>
<td class="label">MitoQ</td>
<td>Mitochondria</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/glioma" style="color:#ef9a9a">Glioma</a>, <a href="/wiki/heart-failure" style="color:#ef9a9a">Heart Failure</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">78 edges</a></td>
</tr>
</table>

CYTC

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CYTC</th>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">Caspase Inhibitors</td>
<td>Block downstream execution</td>
</tr>
<tr>
<td class="label">BCL-2 Agonists</td>
<td>Prevent MOMP</td>
</tr>
<tr>
<td class="label">MitoQ</td>
<td>Mitochondrial antioxidant</td>
</tr>
<tr>
<td class="label">Cytochrome c Sequestration</td>
<td>Prevent cytosolic release</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Target</td>
</tr>
<tr>
<td class="label">VX-166</td>
<td>Caspase-9</td>
</tr>
<tr>
<td class="label">IDN-6556</td>
<td>Pan-caspase</td>
</tr>
<tr>
<td class="label">ABT-737</td>
<td>BCL-2</td>
</tr>
<tr>
<td class="label">MitoQ</td>
<td>Mitochondria</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/glioma" style="color:#ef9a9a">Glioma</a>, <a href="/wiki/heart-failure" style="color:#ef9a9a">Heart Failure</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">78 edges</a></td>
</tr>
</table>

Gene Symbol: CYTC Gene Name: Cytochrome C (Cytochrome c, mitochondrial) Chromosomal Location: 7p14.3 NCBI Gene ID: 9377 Ensembl ID: ENSG00000109854 UniProt ID: P99999

Gene Overview

CYTC encodes cytochrome c, a 104-amino acid mitochondrial electron transport chain protein that plays a dual role in cellular physiology.[@mitochondrial] Beyond its essential function in oxidative phosphorylation, cytochrome c is a critical regulator of [apoptosis](/entities/apoptosis).[@cytochrome] Upon mitochondrial outer membrane permeabilization (MOMP), cytoc[@apoptosome]hrome c is released to the cytosol where it forms the apoptosome with APAF1 (Apoptotic Protease-Activating Factor 1) and activates caspase-9, initiating the intrinsic apoptosis pathway [1](https://pubmed.ncbi.nlm.nih.gov/10625666/). This dual function makes cytochrome c a central player in neuronal survival and death in neurodegenerative diseases [2](https://pubmed.ncbi.nlm.nih.gov/12655290/).

Mitochondrial Electron Transport Chain Function

Complex III Assembly

Cytochrome c is an essential component of the mitochondrial electron transport chain (ETC):

• Location: Resides in the intermembrane space, loosely associated with inner mitochondrial membrane
• Function: Serves as an electron carrier between Complex III (cytochrome bc1 complex) and Complex IV (cytochrome c oxidase)
• Heme Group: Contains covalently attached heme c (bis-histidine heme) essential for electron transfer
• Redox Potential: Exhibits midpoint potential of +0.22 V, enabling efficient electron transfer

Electron Transfer Mechanism

The electron flow through cytochrome c:

Apoptosis Pathway Details

Mitochondrial Outer Membrane Permeabilization (MOMP)

Cytochrome c release is a hallmark of MOMP:

Apoptosome Formation

The apoptosome is a heptameric complex:

• APAF1: Seven copies of Apoptotic Protease-Activating Factor 1
• Cytochrome c: Seven molecules, one per APAF1 protomer
• dATP/ATP: Required for complex assembly and activation
• Procaspase-9: Recruited and activated within the complex

Caspase Cascade Activation

Once apoptosome forms:

Cytochrome c in Alzheimer's Disease

Amyloid-Beta Induced Release

Multiple mechanisms drive Aβ-induced cytochrome c release:

• Direct Interaction: Aβ binds to mitochondria, causing permeability transition
• Oxidative Stress: ROS directly damages mitochondrial membranes
• BAX Translocation: Aβ triggers BAX activation and mitochondrial targeting
• Calcium Dysregulation: Aβ disrupts calcium homeostasis, enhancing release

Therapeutic Strategies

Targeting cytochrome c pathway in AD:

Cytochrome c in Parkinson's Disease

Mitochondrial Complex I Defect

PD-associated mitochondrial dysfunction:

• Complex I Inhibition: MPTP, rotenone, 6-OHDA inhibit Complex I
• ROS Generation: Enhanced superoxide production
• ATP Depletion: Energy crisis in dopaminergic neurons
• Cytochrome c Release: Consequence of mitochondrial dysfunction

Genetic Susceptibility Genes

PD-linked genes affecting cytochrome c release:

• PINK1: Kinase that phosphorylates parkin; dysfunction leads to enhanced release
• PARKIN: E3 ubiquitin ligase; loss causes accumulation of mitochondrial proteins
• DJ-1: Oxidative stress sensor; mutation sensitizes to release
• LRRK2: May affect mitochondrial dynamics

α-Synuclein Interaction

α-Synuclein aggregation affects mitochondria:

• Binds to mitochondrial membranes
• Disrupts mitochondrial electron transport
• Enhances cytochrome c release
• Triggers apoptotic cascade

Cytochrome c in Stroke

Ischemic Injury Cascade

Stroke triggers rapid cytochrome c release:

• Oxygen Glucose Deprivation: Initial trigger
• Reperfusion Injury: Paradoxical worsening upon blood flow restoration
• Excitotoxicity: Glutamate-mediated calcium influx
• Oxidative Stress: ROS burst during reperfusion

Neuroprotective Strategies

Interventions targeting cytochrome c in stroke:

Cytochrome c in Other Neurodegenerative Diseases

Huntington's Disease

• Mutant huntingtin disrupts mitochondrial function
• Enhanced sensitivity to apoptotic stimuli
• Cytochrome c release in striatal neurons
• Contributes to selective vulnerability

Amyotrophic Lateral Sclerosis

• SOD1 mutations cause mitochondrial dysfunction
• TDP-43 pathology triggers apoptosis
• Motor neuron sensitivity to cytochrome c
• Contributes to progressive weakness

Frontotemporal Dementia

• TDP-43 pathology affects mitochondrial function
• Cytochrome c release in affected neurons
• Contributes to progressive neurodegeneration

Structure-Function Relationships

Heme c Attachment

The heme group is essential for function:

• Covalent Binding: Two thioether bonds to cysteine residues
• Iron Center: Fe^2+/Fe^3+ redox couple for electron transfer
• Axial Histidines: His-18 and His-26 coordinate the iron
• Propionate Groups: Orient heme in binding pocket

Surface Charge Distribution

Cytochrome c has asymmetric charge distribution:

• Positive Patch: Lysine residues for interaction with Complex III
• Negative Patch: Redox-active heme edge
• Membrane Binding: Electrostatic interactions with phospholipids

Evolutionary Conservation

Cytochrome c is highly conserved:

• >90% identity across vertebrate species
• Essential for aerobic respiration
• No functional redundancy in ETC

Therapeutic Development

Small Molecule Inhibitors

Gene Therapy Approaches

• APAF-1 Knockdown: Reduce apoptosome formation
• Caspase-9 Dominant Negative: Block caspase activation
• BCL-2 Overexpression: Enhance survival

Challenges

Summary

Cytochrome c (encoded by CYTC) plays a dual role in cellular physiology: as an essential electron carrier in the mitochondrial electron transport chain and as a critical regulator of apoptosis. In neurodegenerative diseases, cytochrome c release from mitochondria triggers the intrinsic apoptosis pathway, leading to neuronal cell death. The protein represents a potential therapeutic target, though balancing its essential mitochondrial function with apoptosis inhibition remains challenging.

Related Pages

• [Apoptosis Pathway](/mechanisms/apoptosis-neurodegeneration)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Caspase Activation](/mechanisms/caspase-activation)
• [BCL2 Gene Family](/genes/bcl2-family)

Cytochrome c Release Markers

Biomarkers

Cytochrome c release can be monitored:

• Cytosolic Cytochrome c: Immunocytochemistry
• Serum Cytochrome c: Potential biomarker
• Mitochondrial Cytochrome c: Loss from mitochondria

Clinical Implications

• Disease progression monitoring
• Therapeutic response assessment
• Patient stratification

Genetic Variants

CYTC Polymorphisms

• No major disease-causing mutations identified
• Rare variants may affect expression
• Population genetics under study

Research Models

Animal Models

• Knockout Mice: Embryonic lethal - essential for respiration
• Conditional Knockouts: Tissue-specific deletion
• Transgenic Models: Overexpression studies

Cellular Models

• Primary Neurons: Primary cortical and dopaminergic cultures
• iPSC-Derived Neurons: Patient-specific models
• Mitochondrial Preparations: Isolated organelle studies

Future Directions

Emerging Research Areas

Therapeutic Outlook

• Combination approaches targeting multiple points in apoptosis
• Personalized medicine based on genetic background
• Early intervention strategies
• Biomarker-driven patient selection

Key Publications

Disease Associations

Alzheimer's Disease (AD)

Cytochrome c plays a pivotal role in AD pathogenesis:

• Aβ-Induced MOMP: [Amyloid-beta](/proteins/amyloid-beta) peptides promote mitochondrial dysfunction and cytochrome c release [4](https://pubmed.ncbi.nlm.nih.gov/PMC1808712/)
• Caspase Activation: Elevated cytochrome c in cytosol correlates with caspase activation in AD brain
• Neuronal Loss: Cytochrome c-mediated apoptosis contributes to hippocampal and cortical neuron loss
• [Tau](/proteins/tau) Pathology: Hyperphosphorylated tau enhances cytochrome c release

• Caspase inhibitors to block cytochrome c-induced caspase activation
• BCL-2 agonists to prevent MOMP and cytochrome c release
• Mitochondrial protectants to maintain mitochondrial integrity

Parkinson's Disease (PD)

In Parkinson's disease, cytochrome c is central to dopaminergic neuron death:

• Mitochondrial Complex I Deficiency: PD-associated toxins (MPTP, 6-OHDA, rotenone) inhibit Complex I, causing cytochrome c release [5](https://pubmed.ncbi.nlm.nih.gov/11751808/)
• Genetic PD Factors: Mutations in PINK1, PARKIN, DJ-1, and [LRRK2](/entities/lrrk2) affect mitochondrial stability and cytochrome c release
• [Alpha-Synuclein](/proteins/alpha-synuclein): Mutant α-synuclein sensitizes [neurons](/entities/neurons) to cytochrome c-mediated apoptosis
• Substantia Nigra Vulnerability: Dopaminergic neurons show particular sensitivity to cytochrome c release

Stroke and Brain Ischemia

Cerebral ischemia triggers cytochrome c release:

• Acute Phase: Within hours of ischemia, cytochrome c translocates to cytosol in affected neurons
• Reperfusion Injury: Restoration of blood flow exacerbates cytochrome c release through oxidative stress
• Penumbra: Neurons in the ischemic penumbra undergo delayed cytochrome c-mediated apoptosis

• Anti-apoptotic BCL-2 family overexpression
• Caspase inhibitors
• Mitochondrial-targeted antioxidants

Amyotrophic Lateral Sclerosis (ALS)

In ALS, cytochrome c contributes to motor neuron death:

• SOD1 Mutations: Mutant SOD1 proteins cause mitochondrial dysfunction and cytochrome c release
• Caspase Activation: Elevated caspase-9 and caspase-3 activation in ALS spinal cord
• Axonal Degeneration: Cytochrome c release precedes axonal retraction in models

Huntington's Disease

In Huntington's disease:

• Mutant [huntingtin](/proteins/huntingtin) disrupts mitochondrial function
• Enhanced sensitivity to cytochrome c-mediated apoptosis in striatal neurons
• Caspase activation contributes to selective neuronal vulnerability

Expression Pattern

Tissue Distribution

Cytochrome c is expressed in virtually all eukaryotic cells:

• Highest expression in tissues with high metabolic demand (heart, brain, skeletal muscle)
• Ubiquitous mitochondrial expression in neurons and glia

Brain Regional Distribution

In the brain, cytochrome c is highly expressed in:

• [Cortex](/brain-regions/cortex): Pyramidal neurons throughout all layers
• [Hippocampus](/brain-regions/hippocampus): CA1-CA3 pyramidal neurons and dentate gyrus granule cells
• Basal Ganglia: Striatal medium spiny neurons
• Substantia Nigra: Dopaminergic neurons (particularly vulnerable in PD)
• Cerebellum: Purkinje cells and granule cells
• Spinal Cord: Motor neurons

Therapeutic Implications

Neuroprotective Strategies

Targeting cytochrome c pathway for neurodegeneration therapy:

• Pan-caspase inhibitors (IDN-6556, VX-166)
• Selective caspase-9 inhibitors

• BCL-2 overexpression (gene therapy)
• Small molecule BCL-2 activators (ABT-737, Navitoclax)

• Mitochondrial-targeted antioxidants (MitoQ)
• ATP-sensitive potassium channel openers
• Calcium homeostasis modulators

• APAF-1 knockdown
• Cytochrome c sequestration strategies

Challenges

• Balancing essential mitochondrial function with apoptosis regulation
• Timing of intervention in progressive neurodegenerative diseases
• [Blood-brain barrier](/entities/blood-brain-barrier) penetration for therapeutic compounds

Key Publications

Cross-References

• [Apoptosis Pathway](/mechanisms/apoptosis-neurodegeneration)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Stroke](/diseases/stroke)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Caspase Activation](/mechanisms/caspase-activation)
• [BCL2 Gene Family](/genes/bcl2-family)

See Also

• [APAF1 Gene](/genes/apaf1)
• [Caspase-9](/proteins/caspase-9)
• [Mitochondrial Apoptosis](/mechanisms/mitochondrial-apoptosis)
• [Neuroprotection](/therapeutics/neuroprotection)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving CYTC discovered through SciDEX knowledge graph analysis: